Viewing nowGenuwon Glimepiride Tablets
Glimepiride 2mg
Tablet · Prescription medication
Genuwon Science Co., Ltd.

MFDS item code 200303280 · Notified 2003.12.16 · Insurance code 671701870
Improvement of blood glucose control in type 2 diabetes mellitus
This medication assists in improving blood sugar control in patients with type 2 diabetes along with dietary and exercise therapy. It can be used alone, and if blood sugar control is insufficient when used alone, it can be combined with other hypoglycemic agents or insulin. For example, this medication can be used together with metformin when monotherapy with sulfonylureas or metformin is not effective. It can be flexibly used in various situations, making it effective for diabetes management. In summary, this medication is used to improve blood sugar control in patients with type 2 diabetes.
The dose should be adjusted individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, there is little additional benefit with doses above 4 mg, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1–2 week intervals. The potency and duration of action of the previous medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia is promptly controlled by immediate intake of sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal; start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, including glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes or diabetic ketoacidosis, or in a comatose state. Patients who are allergic to this medication or its components, or to sulfonylurea or sulfonamide drugs, should not take it. For patients with severely reduced liver or kidney function, it is recommended to switch to insulin therapy instead of using this medication. Women who are pregnant or may become pregnant, and women who are breastfeeding should not take this medication. Insulin therapy is needed for patients with severe infections, before and after surgery, or those who have suffered serious trauma, and this medication should not be used. In cases of gastrointestinal disturbances such as diarrhea or vomiting, caution should be taken as food absorption may be compromised, increasing the risk of hypoglycemia. This medication contains lactose, so patients with genetic disorders such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take it. During the first week of treatment, the risk of hypoglycemia is high, so blood sugar should be monitored particularly closely, and caution should be exercised for the elderly, malnourished patients, those who skip meals, individuals with irregular eating habits, alcohol consumers, and patients with reduced kidney or liver function. Also, when taking other medications, interactions may affect blood sugar control, so patients must inform their physician or pharmacist. Symptoms of hypoglycemia include headache, severe hunger, nausea, fatigue, dizziness, confusion, drowsiness, and loss of consciousness; if these symptoms occur, sugar should be consumed immediately or medical personnel should be notified. While taking this medication, blurred vision, gastrointestinal symptoms, liver dysfunction, blood abnormalities, and allergic reactions may rarely occur; if unusual symptoms arise, consult a physician immediately. When taking this medication, regular meals, exercise, and weight management should be maintained, and blood sugar and urine tests should be conducted regularly. During pregnancy or breastfeeding, insulin therapy is recommended instead of this medication, and safety and efficacy have not been established for children under 18 years of age. In the case of overdose, hypoglycemia may worsen, so immediate emergency treatment should be sought, and it should be kept out of reach of children. While taking this medication, inform healthcare providers about your diabetes condition and treatment experiences, and consult a physician if lifestyle changes or health status changes occur.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disturbances, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, language abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina pectoris, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photodermatitis, decreased serum sodium levels, taste disorder, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to avoid exposure to air and humidity. Additionally, it should be stored at room temperature between 1°C and 30°C, and not in excessively hot or cold places.
Green rectangular tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Genuwon Science Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.